- Issued substantial tranches of common stock and options at nominal prices ($0.0001 per share)
- Grants to CFO include 15M fully vested options and prior warrant issuance
- High dilution profile under Item 3.02 raises immediate overhead supply risk
?? Negative AI Sentiment (-6.5 / 10)